A geometrical interpretation of critical exponents

We develop the hypothesis that the dynamics of a given system may lead to the activity being constricted to a subset of space, characterized by a fractal dimension smaller than the space dimension. We also address how the response function might be sensitive to this change in dimensionality. We discuss how this phenomenon is observable in growth processes and near critical points for systems in equilibrium. In particular, we determine the fractal dimension $d_f$ for the Ising model and validate it via computer simulations for two dimensions

El paradigma de la irradiación corporal total en la leucemia linfoblástica aguda: efectividad terapéutica frente a los desafíos de toxicidad

Total body irradiation (TBI) is part of the myeloablative conditioning for hematopoietic stem cell transplantation (HSCT) in malignant hematologic disorders. This therapy has recently shown improved survival in acute lymphoblastic leukemia (ALL) compared to chemotherapy-based regimens. However, side effects are a significant limitation, especially in the pediatric population. We retrospectively analyzed the survival of patients with ALL who underwent an HSCT at a tertiary hospital between 1996 and 2009 (N = 69 HSCT in 57 patients). We differentiated a cohort that received TBI (N = 44) from another that did not (N = 25). Subsequently, we interviewed the survivors from the TBI group with a minimum of 10 years of follow-up (N = 18), asking about the presence of side effects. The overall survival (OS) at 2 and 5 years was 79.1% and 65.2% respectively for the TBI group and 66.2% and 55.8% for the non-TBI group, although this difference was not significant (P=.31). The event-free survival (EFS) at 2 and 5 years was 77.3% and 63.6% respectively for the TBI group and 56% and 32% for the non-TBI group (P=.02). The probability of relapse (PR) at 2 years for those who received TBI was 10% compared to 28.6% for those who did not receive TBI (P=.005). Survivors who received TBI developed secondary neoplasms (39%), dyslipidemia (67%), cognitive impairments affecting memory (44%), recurrent respiratory infections (39%), thyroid abnormalities (45%), premature ovarian failure (89%), cataracts (22%), and psychological problems (44%). However, the quality of life, as self-assessed by the patients, was considered good for 83% of the participants. Patients who received TBI had significantly higher EFS and lower PR. However, adverse effects are frequent and significant, although they do not subjectively affect quality of lifeNuestro agradecimiento a los Fondos FEDER (FIS) PI18/01301, y a la Fundación Cris contra el Cáncer (http://criscancer.org), por su apoy

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

Background: The phase IIIb, randomized, parallel-group, placebo-controlled ANDHI double-blind (DB) study extended understanding of the efficacy of benralizumab for patients with severe eosinophilic asthma. Patients from ANDHI DB could join the 56-week ANDHI in Practice (IP) single-arm, open-label extension substudy. Objective: Assess potential for standard-of-care background medication reductions while maintaining asthma control with benralizumab. Methods: Following ANDHI DB completion, eligible adults were enrolled in ANDHI IP. After an 8-week run-in with benralizumab, there were 5 visits to potentially reduce background asthma medications for patients achieving and maintaining protocol-defined asthma control with benralizumab. Main outcome measures for non-oral corticosteroid (OCS)-dependent patients were the proportions with at least 1 background medication reduction (ie, lower inhaled corticosteroid dose, background medication discontinuation) and the number of adapted Global Initiative for Asthma (GINA) step reductions at end of treatment (EOT). Main outcomes for OCS-dependent patients were reductions in daily OCS dosage and proportion achieving OCS dosage of 5 mg or lower at EOT. Results: For non-OCS-dependent patients, 53.3% (n = 208 of 390) achieved at least 1 background medication reduction, increasing to 72.6% (n = 130 of 179) for patients who maintained protocol-defined asthma control at EOT. A total of 41.9% (n = 163 of 389) achieved at least 1 adapted GINA step reduction, increasing to 61.8% (n = 110 of 178) for patients with protocol-defined EOT asthma control. At ANDHI IP baseline, OCS dosages were 5 mg or lower for 40.4% (n = 40 of 99) of OCS-dependent patients. Of OCS-dependent patients, 50.5% (n = 50 of 99) eliminated OCS and 74.7% (n = 74 of 99) achieved dosages of 5 mg or lower at EOT. Conclusions: These findings demonstrate benralizumab's ability to improve asthma control, thereby allowing background medication reduction

Thermodynamics of ketone + amine mixtures. I. Volumetric and speed of sound data at (293.15, 298.15, and 303.15) K for 2-propanone + aniline, + N- methylaniline, or + pyridine systems

Densities, , and speeds of sound, u, of 2-propanone + aniline, + N-methylaniline, or + pyridine systems have been measured at (293.15, 298.15 and 303.15) K and atmospheric pressure using a vibrating tube densimeter and sound analyser Anton Paar model DSA-5000. The and u values were used to calculate excess molar volumes, , and the excess functions at 298.15 K for the speed of sound, , the thermal expansion coefficient, , and for the isentropic compressibility, at 298.15 K. and are both negative magnitudes and increase in the same sequence: aniline < N-methylaniline < pyridine. The and curves are shifted towards higher mole fractions of 2-propanone. The data haven interpreted assuming strong acetone-amine interactions, and weak structural effects

Thermodynamics of ketone + amine mixtures: Part II. Volumetric and speed of sound data at (293.15, 298.15 and 303.15) K for 2-propanone + dipropylamine, + dibutylamine or + triethylamine systems

Densities, , and speeds of sound, u, of 2-propanone + dipropylamine, + dibutylamine or + triethylamine systems have been measured at (293.15, 298.15 and 303.15) K and atmospheric pressure using a vibrating tube densimeter and sound analyser Anton Paar model DSA-5000. The and u values were used to calculate excess molar volumes, , and the excess functions at 298.15 K for the thermal expansion coefficient, , and for the isentropic compressibility, at 298.15 K. , and are positive magnitudes. When replacing dipropylamine by dibutylamine or triethylamine in the studied mixtures, the excess functions increase. This may be ascribed to the interactions between unlike molecules are more important in the former solutions. From the comparison with similar data obtained for 2-propanone + aniline, + N-methylaniline, or + pyridine systems, it is concluded that interactions between unlike molecules are stronger in mixtures containing aromatic amines. Free volume effects are present in solutions with dipropyl or dibutylamine as the curves are shifted towards higher mole fractions of 2-propanone

Thermodynamics of Mixtures Containing a Strongly Polar Compound. 9. Liquid−Liquid Equilibria for ε-Caprolactam + Selected Alkanes

Producción CientíficaThe coexistence curves of the liquid-liquid equilibria (LLE) for systems of -caprolactam with heptane, octane, nonane, decane or 2,2,4-trimethylpentane have been determined by the method of the critical opalescence using a laser scattering technique. All the curves show an upper critical solution temperature (UCST), have a rather horizontal top and their symmetry depends on the size of the alkane. The UCST increases almost linearly with the chain length of the n-alkane. For the octane mixture, the UCST is lower than for the solution including 2,2,4-trimethylpentane.Consejería de Educación y Cultura of Junta de Castilla y LeónMinisterio de Educación y Ciencia de Españ